New York, NY, October 26, 2006 -- The Journal of the American Medical Directors Association (JAMDA), Official Journal of the American Medical Directors Association, published by Elsevier, has been accepted by Thomson Scientific (formerly ISI), for inclusion in the Science Citation Index Expanded
"Inclusion in ISI is a compelling sign that JAMDA is becoming an important player as a resource in the world of long-term care management and research," said Editor-in-Chief, Dan Osterweil, MD, CMD.
The 2008 Impact Factor will be the first Impact Factor for JAMDA and will cover the 2006 and 2007 volume years.
In the evaluation process, Thomson Scientific stated that JAMDA is a well-produced, high-quality publication whose overall citation rate has increased measurably over the years.
"Our authors made this possible and we anticipate many more influential articles and insights in the area of long-term care research, advocacy and therapies," Dan Osterweil, MD, CMD.
About JAMDA
JAMDA is the official journal of the American Medical Directors Association. Subscribe to JAMDA (http://www.jamda.com/) or join AMDA and receive JAMDA as a member benefit. Committed to the continuous improvement of the quality of patient care through education, advocacy, information, and professional development for health care professionals, the Journal of the American Medical Directors Association provides coverage of the issues most important to healthcare professionals providing long-term care. Peer-reviewed articles include original studies, reviews, clinical experience articles, case reports, and more. The Journal of the American Medical Directors Association is published 9 times a year.
About AMDA
The American Medical Directors Association (AMDA) (http://www.amda.com/) is the professional association of medical directors and physicians practicing in the long term care continuum. AMDA is dedicated to excellence in patient care by providing education, advocacy, information, and professional development.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).